HC Wainwright Cuts BiomX (NYSEAMERICAN:PHGE) Price Target to $15.00

BiomX (NYSEAMERICAN:PHGE) had its price target decreased by HC Wainwright from $21.00 to $15.00 in a research note issued to investors on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the stock.

BiomX Stock Down 4.2%

Shares of NYSEAMERICAN:PHGE opened at $0.54 on Friday. The company’s fifty day moving average is $0.57. BiomX has a 12-month low of $0.48 and a 12-month high of $4.90. The stock has a market capitalization of $9.82 million, a PE ratio of -0.17 and a beta of 1.27.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).